Cardiol Therapeutics(TSE:CRDL)
CA$1.390.00 (0.00%)
TSE:CRDL
Cardiol Therapeutics financials statements
CA$1.39
At close:0.00 (0.00%)
Want to see TSE:CRDL full AI Analyst Report?
Cardiol Therapeutics (CRDL) Income Statement
236 Followers
Cardiol Therapeutics Income Statement
Last quarter (Q3 2026), Cardiol Therapeutics's total revenue was C$0.00. In Q3, Cardiol Therapeutics's net income was C$-13.32M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 78.76K | |
| C$ 0.00 | C$ -373.11K | C$ -248.35K | C$ -219.91K | C$ 78.76K | |
| C$ 34.32M | C$ 39.90M | C$ 29.54M | C$ 41.34M | C$ 38.74M | |
| Depreciation and Amortization | C$ 101.98K | C$ 373.11K | C$ 248.35K | C$ 219.91K | C$ 220.42K |
| C$ -34.21M | C$ -36.30M | C$ -27.88M | C$ -30.71M | C$ -38.44M | |
| C$ -34.32M | C$ -40.28M | C$ -29.79M | C$ -50.34M | C$ -45.47M | |
| C$ 497.42K | C$ 3.60M | C$ 1.66M | C$ 10.41M | C$ 7.03M | |
| C$ -33.82M | C$ -36.68M | C$ -28.13M | C$ -30.93M | C$ -31.64M | |
| C$ -33.82M | C$ -36.68M | C$ -28.13M | C$ -11.52M | C$ -24.72M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.39 | C$ -0.51 | C$ -0.44 | C$ -0.18 | C$ -0.57 |
| Diluted EPS | C$ -0.39 | C$ -0.51 | C$ -0.44 | C$ -0.18 | C$ -0.57 |
| Weighted Average Shares Outstanding | 86.99M | 71.57M | 64.46M | 62.51M | 43.22M |
| Weighted Average Shares Outstanding (Diluted) | 86.99M | 71.57M | 64.46M | 62.51M | 43.22M |
Currency in CAD

